Related references
Note: Only part of the references are listed.Drug Therapies and the Risk of Malignancy in Crohn's Disease: Results From the TREAT™ Registry
Gary R. Lichtenstein et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
Methotrexate in Combination With Infliximab Is No More Effective Than Infliximab Alone in Patients With Crohn's Disease
Brian G. Feagan et al.
GASTROENTEROLOGY (2014)
Combination Therapy With Infliximab and Azathioprine Is Superior to Monotherapy With Either Agent in Ulcerative Colitis
Remo Panaccione et al.
GASTROENTEROLOGY (2014)
Association Between 6-Thioguanine Nucleotides Levels and Clinical Remission in Inflammatory Disease: A Meta-analysis
Amelie Carla Moreau et al.
INFLAMMATORY BOWEL DISEASES (2014)
Costs of adalimumab versus infliximab as first-line biological therapy for luminal Crohn's disease
Grace K. H. Choi et al.
JOURNAL OF CROHNS & COLITIS (2014)
Extra-intestinal malignancies in inflammatory bowel disease: Results of the 3rd ECCO Pathogenesis Scientific Workshop (III)
Fernando Magro et al.
JOURNAL OF CROHNS & COLITIS (2014)
Treating beyond symptoms with a view to improving patient outcomes in inflammatory bowel diseases
William J. Sandborn et al.
JOURNAL OF CROHNS & COLITIS (2014)
Costs of adalimumab versus infliximab as first-line biological therapy for luminal Crohn's disease
Grace K. H. Choi et al.
JOURNAL OF CROHNS & COLITIS (2014)
Predictors of relapse in patients with Crohn's disease in remission after 1 year of biological therapy
T. Molnar et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2013)
T-Cell Non-Hodgkin's Lymphomas Reported to the FDA AERS With Tumor Necrosis Factor-Alpha (TNF-α) Inhibitors: Results of the REFURBISH Study
Parakkal Deepak et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Placental Transfer of Anti-Tumor Necrosis Factor Agents in Pregnant Patients With Inflammatory Bowel Disease
Uma Mahadevan et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Effects of Discontinuing Anti-Tumor Necrosis Factor Therapy During Pregnancy on the Course of Inflammatory Bowel Disease and Neonatal Exposure
Zuzana Zelinkova et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Adalimumab and Infliximab Are Equally Effective for Crohn's Disease in Patients Not Previously Treated With Anti-Tumor Necrosis Factor-α Agents
Christine Kestens et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Addition of an Immunomodulator to Infliximab Therapy Eliminates Antidrug Antibodies in Serum and Restores Clinical Response of Patients With Inflammatory Bowel Disease
Shomron Ben-Horin et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Long-term Outcome of Perianal Fistulizing Crohn's Disease Treated With Infliximab
Guillaume Bouguen et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Systematic Review and Meta-analysis on the Effects of Thiopurines on Birth Outcomes from Female and Male Patients with Inflammatory Bowel Disease
Mona Akbari et al.
INFLAMMATORY BOWEL DISEASES (2013)
Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn's patients
Filip Baert et al.
JOURNAL OF CROHNS & COLITIS (2013)
Pregnancy and newborn outcome of mothers with inflammatory bowel diseases exposed to anti-TNF-α therapy during pregnancy: three-center study
Martin Bortlik et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2013)
Does co-treatment with immunosuppressors improve outcome in patients with Crohn's disease treated with adalimumab?
C. Reenaers et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ Registry
Gary R. Lichtenstein et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Methotrexate reduces immunogenicity in adalimumab treated rheumatoid arthritis patients in a dose dependent manner
Charlotte L. Krieckaert et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Risk of Melanoma and Nonmelanoma Skin Cancer Among Patients With Inflammatory Bowel Disease
Millie D. Long et al.
GASTROENTEROLOGY (2012)
Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped
Edouard Louis et al.
GASTROENTEROLOGY (2012)
OP11 Individualised infliximab treatment using therapeutic drug monitoring: A prospective controlled Trough level Adapted infliXImab Treatment (TAXIT) trial
N. Vande Casteele et al.
Journal of Crohns & Colitis (2012)
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
Axel Dignass et al.
JOURNAL OF CROHNS & COLITIS (2012)
Outcome after discontinuation of infliximab in patients with inflammatory bowel disease in clinical remission: an observational Danish single center study
Casper Steenholdt et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2012)
Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study
M. van den Broek et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis
Xavier Mariette et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Advanced Age Is an Independent Risk Factor for Severe Infections and Mortality in Patients Given Anti-Tumor Necrosis Factor Therapy for Inflammatory Bowel Disease
Mario Cottone et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
A Systematic Review of Factors That Contribute to Hepatosplenic T-Cell Lymphoma in Patients With Inflammatory Bowel Disease
David S. Kotlyar et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)
Transplacental Transfer of Immunosuppressants and Biologics Used for the Treatment of Inflammatory Bowel Disease
Maria Chaparro et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
Relapse Rate Following Azathioprine Withdrawal in Maintaining Remission for Crohn's Disease: A Meta-Analysis
Helen French et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
Meta-analysis: efficacy and safety of combination therapy of infliximab and immunosuppressives for Crohn's disease
Ziwei Lin et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2011)
Increased Risk for Nonmelanoma Skin Cancers in Patients Who Receive Thiopurines for Inflammatory Bowel Disease
Laurent Peyrin-Biroulet et al.
GASTROENTEROLOGY (2011)
Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study
Jessica Coelho et al.
GUT (2011)
Early use of immunosuppressives or TNF antagonists for the treatment of Crohn's disease: time for a change
Ingrid Ordas et al.
GUT (2011)
A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-α) inhibitors, adalimumab and infliximab, for Crohn's disease
J. Dretzke et al.
HEALTH TECHNOLOGY ASSESSMENT (2011)
Cancer in Crohn's Disease Patients Treated with Infliximab: A Long-term Multicenter Matched Pair Study
Livia Biancone et al.
INFLAMMATORY BOWEL DISEASES (2011)
Combined Approach with Infliximab, Surgery, and Methotrexate in Severe Fistulizing Anoperineal Crohn's Disease: Results from a Prospective Study
Pauline Roumeguere et al.
INFLAMMATORY BOWEL DISEASES (2011)
Use of Thiopurine Testing in the Management of Inflammatory Bowel Diseases in Clinical Practice: A Worldwide Survey of Experts
Xavier Roblin et al.
INFLAMMATORY BOWEL DISEASES (2011)
Development of the Crohn's Disease Digestive Damage Score, the Lemann Score
Benjamin Pariente et al.
INFLAMMATORY BOWEL DISEASES (2011)
Outcome of Pregnancy in Women with Inflammatory Bowel Disease Treated with Antitumor Necrosis Factor Therapy
Fabian Schnitzler et al.
INFLAMMATORY BOWEL DISEASES (2011)
Paternal Exposure to Methotrexate and Pregnancy Outcomes
Delphine Beghin et al.
JOURNAL OF RHEUMATOLOGY (2011)
Maintenance of clinical benefit in Crohn's disease patients after discontinuation of infliximab: long-term follow-up of a single centre cohort
A. W. G. Waugh et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
The Natural History of Adult Crohn's Disease in Population-Based Cohorts
Laurent Peyrin-Biroulet et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Predictors of Infliximab Failure After Azathioprine Withdrawal in Crohn's Disease Treated With Combination Therapy
Abderrahim Oussalah et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Patients with RA in remission on TNF blockers: when and in whom can TNF blocker therapy be stopped?
Benazir Saleem et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease
Filip Baert et al.
GASTROENTEROLOGY (2010)
Usefulness of co-treatment with immunomodulators in patients with inflammatory bowel disease treated with scheduled infliximab maintenance therapy
Harry Sokol et al.
GUT (2010)
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
A. Dignass et al.
JOURNAL OF CROHNS & COLITIS (2010)
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease.
Jean Frederic Colombel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Predictors of persistence with 5-aminosalicylic acid therapy for ulcerative colitis
S. V. Kane et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Systematic review: impact of non-adherence to 5-aminosalicylic acid products on the frequency and cost of ulcerative colitis flares
P. D. R. Higgins et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Prospective Evaluation of Anti-Tumor Necrosis Factor Therapy Guided by Magnetic Resonance Imaging for Crohn's Perineal Fistulas
Siew C. Ng et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Maintenance Treatment With Azathioprine in Ulcerative Colitis: Outcome and Predictive Factors After Drug Withdrawal
Andrea Cassinotti et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Adverse Events Associated With Common Therapy Regimens for Moderate-to-Severe Crohn's Disease
Josh Marehbian et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Azathioprine Withdrawal in Patients With Crohn's Disease Maintained on Prolonged Remission: A High Risk of Relapse
Xavier Treton et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study
H. Fidder et al.
GUT (2009)
European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease
J. F. Rahier et al.
JOURNAL OF CROHNS & COLITIS (2009)
Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study
Laurent Beaugerie et al.
LANCET (2009)
Sustained effect after lowering high-dose infliximab in patients with rheumatoid arthritis: a prospective dose titration study
B. J. F. van den Bemt et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a Randomized trial
Gert Van Assche et al.
GASTROENTEROLOGY (2008)
Risk factors for opportunistic infections in patients with inflammatory bowel disease
Murat Toruner et al.
GASTROENTEROLOGY (2008)
Mortality by medication use among patients with inflammatory bowel disease, 1996-2003
Susan M. Hutfless et al.
GASTROENTEROLOGY (2007)
Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn's disease
Severine Vermeire et al.
GUT (2007)
Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: The CHARM trial
Jean-Frederic Colombel et al.
GASTROENTEROLOGY (2007)
Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry
GR Lichtenstein et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
The safety of infliximab, combined with background treatments, among patients with rheumatoid arthritis and various comorbidities - A large, randomized, placebo-controlled trial
R Westhovens et al.
ARTHRITIS AND RHEUMATISM (2006)
Infliximab plus azathioprine for steroid-dependent Crohn's disease patients:: A randomized placebo-controlled trial
M Lémann et al.
GASTROENTEROLOGY (2006)
Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: A systematic review and metaanalysis of observational studies
FS Velayos et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
A randomized, douuble-blind, controlled withdrawal trial in Crohn's disease patients in long-term remission on azathioprine
M Lémann et al.
GASTROENTEROLOGY (2005)
Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease
U Mahadevan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Systematic review: short-term adverse effects of 5-aminosalicylic acid agents in the treatment of ulcerative colitis
EV Loftus et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
SB Hanauer et al.
LANCET (2002)
Share Paper
